Amanda Jeske
Overview
Explore the profile of Amanda Jeske including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alhallak K, Sun J, Muz B, Jeske A, ONeal J, Ritchey J, et al.
J Cell Mol Med
. 2022 Jan;
26(3):940-944.
PMID: 35014164
Immunotherapy is an attractive approach for treating cancer. T-cell engagers (TCEs) are a type of immunotherapy that are highly efficacious; however, they are challenged by weak T-cell activation and short...
2.
Alhallak K, Jeske A, de la Puente P, Sun J, Fiala M, Azab F, et al.
Sci Rep
. 2021 Sep;
11(1):19343.
PMID: 34588522
Cancer patients undergo detrimental toxicities and ineffective treatments especially in the relapsed setting, due to failed treatment attempts. The development of a tool that predicts the clinical response of individual...
3.
Alhallak K, Sun J, Muz B, Jeske A, Yavner J, Bash H, et al.
Oncotarget
. 2021 Sep;
12(19):1878-1885.
PMID: 34548905
Acute myeloid leukemia (AML) is the most common type of leukemia and has a 5-year survival rate of 25%. The standard-of-care for AML has not changed in the past few...
4.
Alhallak K, Sun J, Jeske A, Park C, Yavner J, Bash H, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34201007
MM is the second most common hematological malignancy and represents approximately 20% of deaths from hematopoietic cancers. The advent of novel agents has changed the therapeutic landscape of MM treatment;...
5.
Alhallak K, de la Puente P, Jeske A, Sun J, Muz B, Rettig M, et al.
Leuk Lymphoma
. 2021 May;
62(10):2457-2465.
PMID: 33993837
Chronic myeloid leukemia (CML), acute myeloid leukemia (AML), and chronic lymphocytic leukemia (CLL) are hematological malignancies that remain incurable despite novel treatments. In order to improve current treatments and clinical...
6.
Federico C, Sun J, Muz B, Alhallak K, Cosper P, Muhammad N, et al.
Int J Radiat Oncol Biol Phys
. 2020 Nov;
109(5):1483-1494.
PMID: 33253820
Purpose: Cervical cancer represents the fourth most frequent malignancy in the world among women, and mortality has remained stable for the past 4 decades. Intravenous cisplatin with concurrent radiation therapy...